The financial effects of kidney stone prevention.
The financial effects of kidney stone prevention.
复制标题
预防肾结石的财务影响。
DOI：
10.1038/ki.1996.489
复制
发表时间：
1996
影响因子：
19.6
通讯作者：
Coe,FL
中科院分区：
文献类型：
--
作者：
Parks,JH;Coe,FL
预防肾结石的财务效果预防肾结石(NL)现在在医学上是可行的，并得到了广泛的推荐。然而，诊断和治疗结石的可补救原因需要测试和药物，这会带来成本；这一成本由与结石相关的事件和医疗事故的假定减少来平衡。为了评估两者之间的平衡，我们分析了1092名未被选择的NL患者的结果，除了在治疗期间进行临床随访外。从这一人群中，我们得出了新结石、住院、膀胱镜检查和外科手术的比率的变化。根据这些变化，以及一系列可能的美元成本的分配，我们估计，医疗结石预防将导致平均节省2,158±500美元(Sem)/患者/年，这是每个患者每年1,068美元的药物和检测支出与每个患者减少3,226美元医疗成本之间的差额。NL的医学预防似乎在节省成本的基础上是合理的，除了它对患者的好处之外，它还可以减少发病率和手术、梗阻和感染的风险。
The financial effects of kidney stone prevention.Prevention of nephrolithiasis (NL) is now medically feasible and widely recommended. However, diagnosis and treatment of remediable causes of stones requires testing and drugs that impose a cost; this cost is balanced by the presumed reductions in stone related events and medical encounters. In order to assess the balance between these, we have analyzed results from 1092 patients with NL unselected except for having clinical follow-up during treatment. From this population, we have derived the changes in rates of new stones, hospitalizations, cystoscopies, and surgical procedures. From these changes, and assignment of a range of possible dollar costs, we estimate that medical stone prevention will result in an average saving of $2,158 ± $500 (sem)/patient/year, which is the difference between an expenditure of $1,068/patient on yearly drugs and testing, and a reduction of $3,226 per patient in medical costs. Medical prevention of NL seems justified on a cost saving basis quite apart from its benefits to patients in terms of reduced morbidity and risk from procedures, obstruction, and infection.